Performance in Initiating Research – Lancashire Care NHS Foundation Trust – Q2 2016-17

Id / Research Ethics Committee Reference Number / Integrated Research Application System Number / Submission Type / Name of Trial / Date of Receipt of Valid Research Application / Date of NHS Permission / First Patient Recruited? / Date of First Patient Recruited / Duration between VRA and NHS Permission / Duration between NHS Permission and First Patient / Duration between VRA and First Patient / Benchmark Met / Date Site Invited / Date Site Selected / HRA Approval Date / Date Site Confirmed By Sponsor / Date Site Confirmed / Non-Confirmation Status / Date Site Ready To Start / A - Permissions delayed/denied / B - Suspended by sponsor / C - Closed by sponsor / D - Sponsor Delays / E - Staff availability issues / F - No patients seen / G - No patients consented / H - Contracting delays / I - Rare diseases / J - Other / Comments / Reasons for delay correspond to:
87199 / 15/NW/0732 / 179111 / NHS Permission / REACT; An online randomised controlled trial to evaluate the clinical and cost effectiveness of a peer supported self -management intervention for relatives of people with psychosis or bipolar disorder: Relatives Education And Coping Toolkit / 14/10/2015 / 14/10/2015 / Yes / 25/04/2016 / 0 / 194 / 194 / No / Please Select... / Y / Y / Study required permission in order to start receiving referrals. The study uses an online tool and is due to start in Feb 2016. / Sponsor
87200 / 15/WA/0178 / 173946 / NHS Permission / E-SEE Trial v1 - Enhancing Social-Emotional Health and Wellbeing in the Early Years: A Community-based Randomised Controlled Trial (and Economic) Evaluation of the Incredible Years Infant and Toddler (02) Parenting Programmes / 16/10/2015 / 16/10/2015 / Yes / 10/11/2015 / 0 / 25 / 25 / Yes / Please Select... / Please Select...
87201 / 15/YH/0343 / 167877 / NHS Permission / ADOPTS: Accelerating Delivery Of Psychological Therapies after Stroke / 14/10/2015 / 04/11/2015 / Yes / 02/12/2015 / 21 / 28 / 49 / Yes / Please Select... / Please Select...
87202 / 14/EM/1305 / 164965 / NHS Permission / AVURT: Phase II randomised double blind, parallel group, placebocontrolled trial comparing the effect of the addition of 300mg daily dose of Aspirin plus standard care on the healing time of venous leg ulcers / 11/11/2015 / 11/11/2015 / Yes / 06/01/2016 / 0 / 56 / 56 / Yes / Please Select... / Y / The was no available medic to prescribe the study drugs. / NHS Provider
87203 / 15/WA/0314 / 179723 / NHS Permission / ENGAGER: Evaluation of a collaborative care intervention for offenders / 08/01/2016 / 13/01/2016 / Yes / 10/02/2016 / 5 / 28 / 33 / Yes / Please Select... / Please Select...
87204 / 15/YH/0051 / 172273 / NHS Permission / SCIMITAR: Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR): a definitive randomised evaluation of a bespoke smoking cessation service. / 29/02/2016 / 29/02/2016 / Yes / 16/03/2016 / 0 / 16 / 16 / Yes / Please Select... / Please Select...
87205 / 15/NW/0371 / 172337 / NHS Permission / ReaDy Speech: A Feasibility Study / 25/01/2016 / 02/02/2016 / Yes / 12/04/2016 / 8 / 70 / 78 / No / Please Select... / Limited pool of eligible patients / NHS Provider
87206 / 14/NW/1117 / 144839 / NHS Permission / Embedding a human rights based approach to Dementia care / 28/04/2016 / 16/05/2016 / Yes / 25/05/2016 / 18 / 9 / 27 / Yes / Please Select... / Please Select...
87207 / 16/NE/0023 / 190035 / NHS Permission / CREAD: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Crenezumab in Patients with Prodromal to Mild Alzheimer’s / 03/08/2016 / 05/09/2016 / No / 33 / Within 70 Days / Please Select... / Please Select...
87208 / 14/LO/1696 / 158559 / NHS Permission / Mentalization Based Therapy (MBT) for Antisocial Personality Disorder: A Pilot Randomised Controlled Trial (MOAM) / 06/07/2016 / 04/08/2016 / Yes / 09/09/2016 / 29 / 36 / 65 / Yes / Please Select... / Please Select...
87209 / 13/LO/0699 / 109089 / NHS Permission / ELAD: Evaluating the effects of the novel GLP-1 analogue, liraglutide, in patients with Alzheimer's disease / 08/07/2016 / 16/08/2016 / No / 39 / No / Please Select... / all eligible patients have screen failed / Neither